Clinical and Experimental Pediatrics

Search

Page Path

HOME
Search

Review Article

Allergy

Montelukast use over the past 20 years: monitoring of its effects and safety issues

Yong Ju Lee, Chang-Keun Kim

Clin Exp Pediatr. 2020;63(10):376-381. Published online February 5, 2020

Cited By 4

Although the efficacy of montelukast is inferior to that of ICS, both physicians and parents prefer montelukast to ICSs.
EDN may be a useful biomarker for the treatment and monitoring of preschool children with asthma.
The US FDA requires boxed warning about serious neuropsychiatric events of montelukast, therefore, physicians should consider the benefits and risks of montelukast before prescribing it.

DOI: https://doi.org/10.3345/cep.2019.00325

Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma

Chang-Keun Kim

Clin Exp Pediatr. 2013;56(1):8-12. Published online January 29, 2013

Cited By 16

Asthma is associated with increased levels of eosinophils in tissues, body fluids, and bone marrow. Elevated levels of eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP) have been noted in asthma patients. Higher levels of EDN and ECP are also associated with exacerbated asthmatic conditions. Thus, EDN, along with ECP, may aid the diagnosis and monitoring of asthma. Several groups...

DOI: https://doi.org/10.3345/kjp.2013.56.1.8

MOST CITED AHEAD-OF PRINT

Cited By 180	Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)
Cited By 94	Epidemiology and clinical features of coronavirus disease 2019 in children
Cited By 33	Ten-year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008–2017
Cited By 20	Immunopathogenesis of COVID-19 and early immunomodulators
Cited By 19	High-flow nasal cannula oxygen therapy in children: a clinical review